English

DEPOMED INC

EDGAR

ASRT Quarterly report (10-Q) · filed 2020-05-11

160 filing records in this dataset, filed from 1997-12-19 to 2020-05-11. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

20.9 million USD

2020 Q1 · USD

Exact inputs and evidence

Revenue: 20917000 USD Source

Operating margin

-79.51%

2020 Q1 · %

Exact inputs and evidence

Operating Income: -16632000 USD Source
Revenue: 20917000 USD Source

Operating cash flow

-25.1 million USD

2020 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -25063000 USD Source

Free cash flow

-25.1 million USD

2020 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -25063000 USD Source
Capital Expenditure: 9000 USD Source

Cash and cash equivalents: 106 million USD 2020-03-31 Source
Exact value

105973000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 80.9 million shares 2019-12-31 Source
Exact value

80888134 shares

Reported share-count change

26.02% · 16.7 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

64185224 shares · 2018-12-31· Source
80888134 shares · 2019-12-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2020-05-11.

Financial data available through: 2019-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2019-12-31
Operating income: 7 of 11 periods available· newest 2019-12-31
Net income: 7 of 11 periods available· newest 2019-12-31
Operating cash flow: 7 of 11 periods available· newest 2019-12-31
Capital expenditure: 7 of 11 periods available· newest 2019-12-31
Total assets: 5 of 11 periods available· newest 2019-12-31
Total liabilities: 3 of 11 periods available· newest 2019-12-31
Current assets: 6 of 11 periods available· newest 2019-12-31
Current liabilities: 6 of 11 periods available· newest 2019-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2019-12-31
long term debt: No compatible figures in this window
Shares outstanding: 5 of 11 periods available· newest 2019-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-26.4%

Prior period

USD 311.77 million

2018-01-01 – 2018-12-31
Current period

USD 229.5 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

229504000 − 311770000 = -82266000 USD

311770000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
229504000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · DEPOMED INC · 2019-12-31 DEPOMED INC (edgar:1005201) Year-over-year change in Revenue: -82266000 USD Concept: fundies:Revenue Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 229504000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#604247 Filing: 000100520120000021 Input fundies:Revenue: 311770000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#597957 Filing: 000100520120000021
The citation records this snapshot. The page link may show a newer release later.
Net income
-688.5%

Prior period

USD 36.91 million

2018-01-01 – 2018-12-31
Current period

−USD 217.2 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

-217201000 − 36908000 = -254109000 USD

36908000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
-217201000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · DEPOMED INC · 2019-12-31 DEPOMED INC (edgar:1005201) Year-over-year change in Net income: -254109000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -217201000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#547094 Filing: 000100520120000021 Input fundies:NetIncome: 36908000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#546104 Filing: 000100520120000021
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+24.8%

Prior period

USD 72.5 million

2018-01-01 – 2018-12-31
Current period

USD 90.48 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

90475000 − 72497000 = 17978000 USD

72497000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
90475000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · DEPOMED INC · 2019-12-31 DEPOMED INC (edgar:1005201) Year-over-year change in Operating cash flow: 17978000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 90475000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#544900 Filing: 000100520120000021 Input fundies:OperatingCashFlow: 72497000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#544689 Filing: 000100520120000021
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-73.1%

Prior period

USD 5.51 million

2018-01-01 – 2018-12-31
Current period

USD 1.48 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

1481000 − 5507000 = -4026000 USD

5507000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
1481000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · DEPOMED INC · 2019-12-31 DEPOMED INC (edgar:1005201) Year-over-year change in Capital expenditure: -4026000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1481000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#568649 Filing: 000100520120000021 Input fundies:CapitalExpenditure: 5507000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#568439 Filing: 000100520120000021
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2019 2019-01-01 – 2019-12-31

Revenue USD 229.5 million 100% of revenue
Operating costs Derived USD 423.93 million 185% of revenue
Operating income −USD 194.43 million −85% of revenue
Tax, interest and other Derived USD 22.77 million 9.9% of revenue
Net income −USD 217.2 million −95% of revenue

Cash

Operating cash flow USD 90.48 million 39% of revenue
Capital expenditure USD 1.48 million 0.6% of revenue
Free cash flow Derived USD 88.99 million 39% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2011 Net income was higher than operating income, so the split is not drawn.
2012 Operating loss: operating costs were 133% of revenue.
2013 Net income was higher than operating income, so the split is not drawn.
2016 Net loss: net income was −19% of revenue.
2017 Operating loss: operating costs were 111% of revenue.
2018 12%86%
2019 Operating loss: operating costs were 185% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2011 2011-01-01 – 2011-12-31	132973000	62275000 Derived	70698000	-28000 Derived	70726000	56953000 Derived	Source 2011-01-01 – 2011-12-31: 132973000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: 70698000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: 70726000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: 57651000 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 698000 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	90816000	121169000 Derived	-30353000	-572000 Derived	-29781000	-37865000 Derived	Source 2012-01-01 – 2012-12-31: 90816000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -30353000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -29781000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -30985000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 6880000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	134205000	124888000 Derived	9317000	-33996000 Derived	43313000	7942000 Derived	Source 2013-01-01 – 2013-12-31: 134205000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: 9317000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 43313000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: 9754000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 1812000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	455897000	431388000 Derived	24509000	113229000 Derived	-88720000	68403000 Derived	Source 2016-01-01 – 2016-12-31: 455897000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: 24509000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -88720000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 71263000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 2860000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	380724000	422904000 Derived	-42180000	60316000 Derived	-102496000	61501000 Derived	Source 2017-01-01 – 2017-12-31: 380724000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -42180000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -102496000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 62167000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 666000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	311770000	268111000 Derived	43659000	6751000 Derived	36908000	66990000 Derived	Source 2018-01-01 – 2018-12-31: 311770000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: 43659000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: 36908000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 72497000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 5507000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	229504000	423932000 Derived	-194428000	22773000 Derived	-217201000	88994000 Derived	Source 2019-01-01 – 2019-12-31: 229504000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -194428000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -217201000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 90475000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 1481000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 229.5M 2019

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-12-31	Revenue	132973000	Revenue: 132973000 Open source
20122012-12-31	Revenue	90816000	Revenue: 90816000 Open source
20132013-12-31	Revenue	134205000	Revenue: 134205000 Open source
20162016-12-31	Revenue	455897000	Revenue: 455897000 Open source
20172017-12-31	Revenue	380724000	Revenue: 380724000 Open source
20182018-12-31	Revenue	311770000	Revenue: 311770000 Open source
20192019-12-31	Revenue	229504000	Revenue: 229504000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-26.4% 2019

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20112011-12-31	Year over year	No prior comparable period	Revenue: 132973000 Open source
20122012-12-31	Year over year	-31.7%	Revenue: 90816000 Open source Revenue: 132973000 Open source
20132013-12-31	Year over year	47.8%	Revenue: 134205000 Open source Revenue: 90816000 Open source
20162016-12-31	Year over year	No prior comparable period	Revenue: 455897000 Open source
20172017-12-31	Year over year	-16.5%	Revenue: 380724000 Open source Revenue: 455897000 Open source
20182018-12-31	Year over year	-18.1%	Revenue: 311770000 Open source Revenue: 380724000 Open source
20192019-12-31	Year over year	-26.4%	Revenue: 229504000 Open source Revenue: 311770000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -84.7% 2019

Net margin -94.6% 2019

Free cash flow margin 38.8% 2019

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20112011-12-31	Operating margin	53.2%	Operating Income: 70698000 Open source Revenue: 132973000 Open source
20122012-12-31	Operating margin	-33.4%	Operating Income: -30353000 Open source Revenue: 90816000 Open source
20132013-12-31	Operating margin	6.9%	Operating Income: 9317000 Open source Revenue: 134205000 Open source
20162016-12-31	Operating margin	5.4%	Operating Income: 24509000 Open source Revenue: 455897000 Open source
20172017-12-31	Operating margin	-11.1%	Operating Income: -42180000 Open source Revenue: 380724000 Open source
20182018-12-31	Operating margin	14%	Operating Income: 43659000 Open source Revenue: 311770000 Open source
20192019-12-31	Operating margin	-84.7%	Operating Income: -194428000 Open source Revenue: 229504000 Open source
20112011-12-31	Net margin	53.2%	Net Income: 70726000 Open source Revenue: 132973000 Open source
20122012-12-31	Net margin	-32.8%	Net Income: -29781000 Open source Revenue: 90816000 Open source
20132013-12-31	Net margin	32.3%	Net Income: 43313000 Open source Revenue: 134205000 Open source
20162016-12-31	Net margin	-19.5%	Net Income: -88720000 Open source Revenue: 455897000 Open source
20172017-12-31	Net margin	-26.9%	Net Income: -102496000 Open source Revenue: 380724000 Open source
20182018-12-31	Net margin	11.8%	Net Income: 36908000 Open source Revenue: 311770000 Open source
20192019-12-31	Net margin	-94.6%	Net Income: -217201000 Open source Revenue: 229504000 Open source
20112011-12-31	Free cash flow margin	42.8%	Revenue: 132973000 Open source Operating Cash Flow: 57651000 Open source Capital Expenditure: 698000 Open source
20122012-12-31	Free cash flow margin	-41.7%	Revenue: 90816000 Open source Operating Cash Flow: -30985000 Open source Capital Expenditure: 6880000 Open source
20132013-12-31	Free cash flow margin	5.9%	Revenue: 134205000 Open source Operating Cash Flow: 9754000 Open source Capital Expenditure: 1812000 Open source
20162016-12-31	Free cash flow margin	15%	Revenue: 455897000 Open source Operating Cash Flow: 71263000 Open source Capital Expenditure: 2860000 Open source
20172017-12-31	Free cash flow margin	16.2%	Revenue: 380724000 Open source Operating Cash Flow: 62167000 Open source Capital Expenditure: 666000 Open source
20182018-12-31	Free cash flow margin	21.5%	Revenue: 311770000 Open source Operating Cash Flow: 72497000 Open source Capital Expenditure: 5507000 Open source
20192019-12-31	Free cash flow margin	38.8%	Revenue: 229504000 Open source Operating Cash Flow: 90475000 Open source Capital Expenditure: 1481000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 90.5M 2019

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-12-31	Operating cash flow	57651000	Operating Cash Flow: 57651000 Open source
20122012-12-31	Operating cash flow	-30985000	Operating Cash Flow: -30985000 Open source
20132013-12-31	Operating cash flow	9754000	Operating Cash Flow: 9754000 Open source
20162016-12-31	Operating cash flow	71263000	Operating Cash Flow: 71263000 Open source
20172017-12-31	Operating cash flow	62167000	Operating Cash Flow: 62167000 Open source
20182018-12-31	Operating cash flow	72497000	Operating Cash Flow: 72497000 Open source
20192019-12-31	Operating cash flow	90475000	Operating Cash Flow: 90475000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 89M 2019

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20112011-12-31	Free cash flow	56953000	Operating Cash Flow: 57651000 Open source Capital Expenditure: 698000 Open source
20122012-12-31	Free cash flow	-37865000	Operating Cash Flow: -30985000 Open source Capital Expenditure: 6880000 Open source
20132013-12-31	Free cash flow	7942000	Operating Cash Flow: 9754000 Open source Capital Expenditure: 1812000 Open source
20162016-12-31	Free cash flow	68403000	Operating Cash Flow: 71263000 Open source Capital Expenditure: 2860000 Open source
20172017-12-31	Free cash flow	61501000	Operating Cash Flow: 62167000 Open source Capital Expenditure: 666000 Open source
20182018-12-31	Free cash flow	66990000	Operating Cash Flow: 72497000 Open source Capital Expenditure: 5507000 Open source
20192019-12-31	Free cash flow	88994000	Operating Cash Flow: 90475000 Open source Capital Expenditure: 1481000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

89% 2019

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2011-12-31	Liabilities / assets	Not reported	No source recorded
2012-12-31	Liabilities / assets	Not reported	Total Assets: 141653000 Open source
2013-12-31	Liabilities / assets	Not reported	Total Assets: 508653000 Open source
2016-12-31	Liabilities / assets	Not reported	No source recorded
20172017-12-31	Liabilities / assets	83.7%	Total Liabilities: 869109000 Open source Total Assets: 1038617000 Open source
20182018-12-31	Liabilities / assets	76.4%	Total Liabilities: 712531000 Open source Total Assets: 932866000 Open source
20192019-12-31	Liabilities / assets	89%	Total Liabilities: 469212000 Open source Total Assets: 527170000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.56× 2019

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2011-12-31	Current assets / current liabilities	Not reported	No source recorded
20122012-12-31	Current assets / current liabilities	2.6×	Current Assets: 95267000 Open source Current Liabilities: 36681000 Open source
20132013-12-31	Current assets / current liabilities	2.15×	Current Assets: 337045000 Open source Current Liabilities: 156857000 Open source
2016-12-31	Current assets / current liabilities	Not reported	No source recorded
20172017-12-31	Current assets / current liabilities	0.74×	Current Assets: 230851000 Open source Current Liabilities: 310580000 Open source
20182018-12-31	Current assets / current liabilities	0.85×	Current Assets: 208107000 Open source Current Liabilities: 246036000 Open source
20192019-12-31	Current assets / current liabilities	0.56×	Current Assets: 103951000 Open source Current Liabilities: 184553000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2011 2011-01-01 – 2011-12-31	USD 70.73 million Exact value Exact value: 70726000 USD 2011-01-01 – 2011-12-31: 70726000 USD Inspect Net Income Open source Share or cite Citation for Net Income · DEPOMED INC · 2011-12-31 DEPOMED INC (edgar:1005201) Net Income: 70726000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: 70726000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000104746914002523/depo-20131231.xml#1200304 Filing: 000104746914002523 The citation records this snapshot. The page link may show a newer release later.	USD 57.65 million Exact value Exact value: 57651000 USD 2011-01-01 – 2011-12-31: 57651000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DEPOMED INC · 2011-12-31 DEPOMED INC (edgar:1005201) Operating Cash Flow: 57651000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 57651000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000104746914002523/depo-20131231.xml#1209540 Filing: 000104746914002523 The citation records this snapshot. The page link may show a newer release later.	USD 698,000 Exact value Exact value: 698000 USD 2011-01-01 – 2011-12-31: 698000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DEPOMED INC · 2011-12-31 DEPOMED INC (edgar:1005201) Capital Expenditure: 698000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 698000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000104746914002523/depo-20131231.xml#1209929 Filing: 000104746914002523 The citation records this snapshot. The page link may show a newer release later.	USD 56.95 million Calculation and evidence 57651000 − 698000 USD Exact free cash flow: 56953000 USD 2011-01-01 – 2011-12-31: 57651000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 698000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DEPOMED INC · 2011-12-31 DEPOMED INC (edgar:1005201) Free cash flow: 56953000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 57651000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000104746914002523/depo-20131231.xml#1209540 Filing: 000104746914002523 Input fundies:CapitalExpenditure: 698000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000104746914002523/depo-20131231.xml#1209929 Filing: 000104746914002523 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 29.78 million Exact value Exact value: -29781000 USD 2012-01-01 – 2012-12-31: -29781000 USD Inspect Net Income Open source Share or cite Citation for Net Income · DEPOMED INC · 2012-12-31 DEPOMED INC (edgar:1005201) Net Income: -29781000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -29781000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000104746914002523/depo-20131231.xml#1205265 Filing: 000104746914002523 The citation records this snapshot. The page link may show a newer release later.	−USD 30.99 million Exact value Exact value: -30985000 USD 2012-01-01 – 2012-12-31: -30985000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DEPOMED INC · 2012-12-31 DEPOMED INC (edgar:1005201) Operating Cash Flow: -30985000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -30985000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000104746914002523/depo-20131231.xml#1215714 Filing: 000104746914002523 The citation records this snapshot. The page link may show a newer release later.	USD 6.88 million Exact value Exact value: 6880000 USD 2012-01-01 – 2012-12-31: 6880000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DEPOMED INC · 2012-12-31 DEPOMED INC (edgar:1005201) Capital Expenditure: 6880000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6880000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000104746914002523/depo-20131231.xml#1215930 Filing: 000104746914002523 The citation records this snapshot. The page link may show a newer release later.	−USD 37.87 million Calculation and evidence -30985000 − 6880000 USD Exact free cash flow: -37865000 USD 2012-01-01 – 2012-12-31: -30985000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 6880000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DEPOMED INC · 2012-12-31 DEPOMED INC (edgar:1005201) Free cash flow: -37865000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -30985000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000104746914002523/depo-20131231.xml#1215714 Filing: 000104746914002523 Input fundies:CapitalExpenditure: 6880000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000104746914002523/depo-20131231.xml#1215930 Filing: 000104746914002523 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	USD 43.31 million Exact value Exact value: 43313000 USD 2013-01-01 – 2013-12-31: 43313000 USD Inspect Net Income Open source Share or cite Citation for Net Income · DEPOMED INC · 2013-12-31 DEPOMED INC (edgar:1005201) Net Income: 43313000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: 43313000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000104746914002523/depo-20131231.xml#1200187 Filing: 000104746914002523 The citation records this snapshot. The page link may show a newer release later.	USD 9.75 million Exact value Exact value: 9754000 USD 2013-01-01 – 2013-12-31: 9754000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DEPOMED INC · 2013-12-31 DEPOMED INC (edgar:1005201) Operating Cash Flow: 9754000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 9754000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000104746914002523/depo-20131231.xml#1209326 Filing: 000104746914002523 The citation records this snapshot. The page link may show a newer release later.	USD 1.81 million Exact value Exact value: 1812000 USD 2013-01-01 – 2013-12-31: 1812000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DEPOMED INC · 2013-12-31 DEPOMED INC (edgar:1005201) Capital Expenditure: 1812000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1812000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000104746914002523/depo-20131231.xml#1209755 Filing: 000104746914002523 The citation records this snapshot. The page link may show a newer release later.	USD 7.94 million Calculation and evidence 9754000 − 1812000 USD Exact free cash flow: 7942000 USD 2013-01-01 – 2013-12-31: 9754000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 1812000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DEPOMED INC · 2013-12-31 DEPOMED INC (edgar:1005201) Free cash flow: 7942000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 9754000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000104746914002523/depo-20131231.xml#1209326 Filing: 000104746914002523 Input fundies:CapitalExpenditure: 1812000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000104746914002523/depo-20131231.xml#1209755 Filing: 000104746914002523 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 88.72 million Exact value Exact value: -88720000 USD 2016-01-01 – 2016-12-31: -88720000 USD Inspect Net Income Open source Share or cite Citation for Net Income · DEPOMED INC · 2016-12-31 DEPOMED INC (edgar:1005201) Net Income: -88720000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -88720000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520119000040/asrt-20181231.xml#557864 Filing: 000100520119000040 The citation records this snapshot. The page link may show a newer release later.	USD 71.26 million Exact value Exact value: 71263000 USD 2016-01-01 – 2016-12-31: 71263000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DEPOMED INC · 2016-12-31 DEPOMED INC (edgar:1005201) Operating Cash Flow: 71263000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 71263000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520119000040/asrt-20181231.xml#557231 Filing: 000100520119000040 The citation records this snapshot. The page link may show a newer release later.	USD 2.86 million Exact value Exact value: 2860000 USD 2016-01-01 – 2016-12-31: 2860000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DEPOMED INC · 2016-12-31 DEPOMED INC (edgar:1005201) Capital Expenditure: 2860000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2860000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520119000040/asrt-20181231.xml#577979 Filing: 000100520119000040 The citation records this snapshot. The page link may show a newer release later.	USD 68.4 million Calculation and evidence 71263000 − 2860000 USD Exact free cash flow: 68403000 USD 2016-01-01 – 2016-12-31: 71263000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 2860000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DEPOMED INC · 2016-12-31 DEPOMED INC (edgar:1005201) Free cash flow: 68403000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 71263000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520119000040/asrt-20181231.xml#557231 Filing: 000100520119000040 Input fundies:CapitalExpenditure: 2860000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520119000040/asrt-20181231.xml#577979 Filing: 000100520119000040 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 102.5 million Exact value Exact value: -102496000 USD 2017-01-01 – 2017-12-31: -102496000 USD Inspect Net Income Open source Share or cite Citation for Net Income · DEPOMED INC · 2017-12-31 DEPOMED INC (edgar:1005201) Net Income: -102496000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -102496000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#545111 Filing: 000100520120000021 The citation records this snapshot. The page link may show a newer release later.	USD 62.17 million Exact value Exact value: 62167000 USD 2017-01-01 – 2017-12-31: 62167000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DEPOMED INC · 2017-12-31 DEPOMED INC (edgar:1005201) Operating Cash Flow: 62167000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 62167000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#544478 Filing: 000100520120000021 The citation records this snapshot. The page link may show a newer release later.	USD 666,000 Exact value Exact value: 666000 USD 2017-01-01 – 2017-12-31: 666000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DEPOMED INC · 2017-12-31 DEPOMED INC (edgar:1005201) Capital Expenditure: 666000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 666000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#568230 Filing: 000100520120000021 The citation records this snapshot. The page link may show a newer release later.	USD 61.5 million Calculation and evidence 62167000 − 666000 USD Exact free cash flow: 61501000 USD 2017-01-01 – 2017-12-31: 62167000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 666000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DEPOMED INC · 2017-12-31 DEPOMED INC (edgar:1005201) Free cash flow: 61501000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 62167000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#544478 Filing: 000100520120000021 Input fundies:CapitalExpenditure: 666000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#568230 Filing: 000100520120000021 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	USD 36.91 million Exact value Exact value: 36908000 USD 2018-01-01 – 2018-12-31: 36908000 USD Inspect Net Income Open source Share or cite Citation for Net Income · DEPOMED INC · 2018-12-31 DEPOMED INC (edgar:1005201) Net Income: 36908000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: 36908000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#546104 Filing: 000100520120000021 The citation records this snapshot. The page link may show a newer release later.	USD 72.5 million Exact value Exact value: 72497000 USD 2018-01-01 – 2018-12-31: 72497000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DEPOMED INC · 2018-12-31 DEPOMED INC (edgar:1005201) Operating Cash Flow: 72497000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 72497000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#544689 Filing: 000100520120000021 The citation records this snapshot. The page link may show a newer release later.	USD 5.51 million Exact value Exact value: 5507000 USD 2018-01-01 – 2018-12-31: 5507000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DEPOMED INC · 2018-12-31 DEPOMED INC (edgar:1005201) Capital Expenditure: 5507000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5507000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#568439 Filing: 000100520120000021 The citation records this snapshot. The page link may show a newer release later.	USD 66.99 million Calculation and evidence 72497000 − 5507000 USD Exact free cash flow: 66990000 USD 2018-01-01 – 2018-12-31: 72497000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 5507000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DEPOMED INC · 2018-12-31 DEPOMED INC (edgar:1005201) Free cash flow: 66990000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 72497000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#544689 Filing: 000100520120000021 Input fundies:CapitalExpenditure: 5507000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#568439 Filing: 000100520120000021 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 217.2 million Exact value Exact value: -217201000 USD 2019-01-01 – 2019-12-31: -217201000 USD Inspect Net Income Open source Share or cite Citation for Net Income · DEPOMED INC · 2019-12-31 DEPOMED INC (edgar:1005201) Net Income: -217201000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -217201000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#547094 Filing: 000100520120000021 The citation records this snapshot. The page link may show a newer release later.	USD 90.48 million Exact value Exact value: 90475000 USD 2019-01-01 – 2019-12-31: 90475000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DEPOMED INC · 2019-12-31 DEPOMED INC (edgar:1005201) Operating Cash Flow: 90475000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 90475000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#544900 Filing: 000100520120000021 The citation records this snapshot. The page link may show a newer release later.	USD 1.48 million Exact value Exact value: 1481000 USD 2019-01-01 – 2019-12-31: 1481000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DEPOMED INC · 2019-12-31 DEPOMED INC (edgar:1005201) Capital Expenditure: 1481000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1481000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#568649 Filing: 000100520120000021 The citation records this snapshot. The page link may show a newer release later.	USD 88.99 million Calculation and evidence 90475000 − 1481000 USD Exact free cash flow: 88994000 USD 2019-01-01 – 2019-12-31: 90475000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1481000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DEPOMED INC · 2019-12-31 DEPOMED INC (edgar:1005201) Free cash flow: 88994000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:39:48Z Snapshot: 93a40e2780717cb50d626e0d14a6a10f76e391653569d133e62b845fff6d393a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 90475000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#544900 Filing: 000100520120000021 Input fundies:CapitalExpenditure: 1481000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005201/000100520120000021/asrt-20191231.xml#568649 Filing: 000100520120000021 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

160 filings · 4,020 latest values · 4,020 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001005201, 1005201, ASRT, edgar:1005201

Also known as ASSERTIO THERAPEUTICS, INC., Assertio Therapeutics, Inc, Assertio Therapeutics, Inc., DEPOMED INC

DEPOMED INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2019 2019-01-01 – 2019-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation